Marrone Bio Innovations Stock

Marrone Bio Innovations EBIT

Delisted

The EBIT of Marrone Bio Innovations (MBII) as of Jul 25, 2026 is -14.94 M USD. In the previous year, EBIT was 1.39 M USD — a change of -1,174.75% (lower).

EBIT

-14.94 MUSD

YoY

-1,174.75%

Last updated:

In 2026, Marrone Bio Innovations's EBIT was -14.94 M USD, a -1,174.75% increase from the 1.39 M USD EBIT recorded in the previous year.

The Marrone Bio Innovations EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M USD)
Date
EBIT (M USD)
Jan 1, 2019
-35.69 base
Jan 1, 2020
1.39 base
Jan 1, 2021
-14.94 base
Jan 1, 2022 (e)
-12.95 base
Jan 1, 2023 (e)
-3.57 base
Jan 1, 2024 (e)
-4.97 base
Jan 1, 2025 (e)
-7.06 base
Jan 1, 2026 (e)
0.00 base
YEAREBIT (M USD)
2026 est -
2025 est -7.06
2024 est -4.97
2023 est -3.57
2022 est -12.95
2021 -14.94
2020 1.39
2019 -35.69
2018 -17.71
2017 -23.20
2016 -23.81
2015 -48.53
2014 -48.53
2013 -29.03
2012 -20.23
2011 -13.12
2010 -7.96
Access this data via the Eulerpool API

Marrone Bio Innovations Revenue

Marrone Bio Innovations Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
29.37 M USD
-35.69 M USD
-37.18 M USD
Jan 1, 2020
100,000.00 USD
1.39 M USD
-53,000.00 USD
Jan 1, 2021
44.31 M USD
-14.94 M USD
-16.55 M USD
Jan 1, 2022 (e)
56.45 M USD
-12.95 M USD
-18.24 M USD
Jan 1, 2023 (e)
71.00 M USD
-3.57 M USD
-3.65 M USD
Jan 1, 2024 (e)
91.80 M USD
-4.97 M USD
-3.72 M USD
Jan 1, 2025 (e)
107.73 M USD
-7.06 M USD
-5.12 M USD
Jan 1, 2026 (e)
118.34 M USD
0.00 USD
-7.20 M USD

Marrone Bio Innovations Margins

Marrone Bio Innovations stock margins

The Marrone Bio Innovations margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Marrone Bio Innovations. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Marrone Bio Innovations.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
54.86 %
-121.49 %
-126.56 %
Jan 1, 2020
60.00 %
1,390.00 %
-53.00 %
Jan 1, 2021
61.49 %
-33.71 %
-37.36 %
Jan 1, 2022 (e)
61.49 %
-22.95 %
-32.31 %
Jan 1, 2023 (e)
61.49 %
-5.03 %
-5.14 %
Jan 1, 2024 (e)
61.49 %
-5.42 %
-4.05 %
Jan 1, 2025 (e)
61.49 %
-6.55 %
-4.76 %
Jan 1, 2026 (e)
61.49 %
0.00 %
-6.08 %

Marrone Bio Innovations Stock analysis

What does Marrone Bio Innovations do? Marrone Bio Innovations Inc is an American company that has been operating in the field of biological pest control since 2006. It was founded by chemist Dr. Pamela Marrone and is headquartered in Davis, California. The company's business model is based on developing safe and effective biological pest control products made from natural ingredients. The aim is to minimize the environmental impact of agriculture. The company is divided into different divisions, including biological plant protection, biological nitrogen fixation, biological weed control, and other products. Some of the well-known products include Regalia®, Venerate®, and Majestene®. Marrone Bio Innovations has gained significance in recent years and is now one of the leading companies in the field of biological pest control. The company works closely with farmers, research institutions, and regulatory authorities to develop and introduce new products, always prioritizing safety and environmental compatibility. Marrone Bio Innovations is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Marrone Bio Innovations's EBIT

Marrone Bio Innovations's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Marrone Bio Innovations's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Marrone Bio Innovations's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Marrone Bio Innovations’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Marrone Bio Innovations stock

EBIT of Marrone Bio Innovations is -14.94 M USD in 2026.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Marrone Bio Innovations

All Key Metrics — Marrone Bio Innovations